201 related articles for article (PubMed ID: 24130758)
21. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
Blackford AL; Canto MI; Klein AP; Hruban RH; Goggins M
J Natl Cancer Inst; 2020 Nov; 112(11):1162-1169. PubMed ID: 31958122
[TBL] [Abstract][Full Text] [Related]
22. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
23. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.
Chen Q; Ning Z; Wang L; Ying H; Dong S; Zhang C; Shen X; Guo Y; Chen H; Zhu X; Shen Y; Shi W; Hua Y; Wang K; Lin J; Xu L; Chen L; Feng L; Zhang X; Xie J; Sun B; Sun Y; Gu W; Kang M; Tang Z; Chen Z; Chen Z; Liu L; Yu J; Li Z; Meng Z
Oncotarget; 2016 Dec; 7(51):85603-85612. PubMed ID: 27811354
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009.
Hu Y; Zhao Q; Rao J; Deng H; Yuan H; Xu B
BMC Public Health; 2014 Apr; 14():356. PubMed ID: 24731197
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic cancer epidemiology and survival in an Australian population.
Luke C; Price T; Karapetis C; Singhal N; Roder D
Asian Pac J Cancer Prev; 2009; 10(3):369-74. PubMed ID: 19640175
[TBL] [Abstract][Full Text] [Related]
26. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the patterns of female breast cancer incidence in Shanghai, 2003-2012].
Wu CX; Zheng Y; Bao PP; Huang ZZ; Zhang ML; Gu K; Xiang YM; Peng P; Gong YM; Zhong WJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):692-697. PubMed ID: 28763917
[No Abstract] [Full Text] [Related]
28. Life expectancy in pancreatic neuroendocrine cancer.
Brooks JC; Shavelle RM; Vavra-Musser KN
Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):88-97. PubMed ID: 30220478
[TBL] [Abstract][Full Text] [Related]
29. Survival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999.
Gong Z; Holly EA; Bracci PM
Am J Epidemiol; 2011 Dec; 174(12):1373-81. PubMed ID: 22047824
[TBL] [Abstract][Full Text] [Related]
30. Comparable prevalence of distant metastasis and survival of different primary site for LN + pancreatic tumor.
Lou X; Li J; Wei YQ; Jiang ZJ; Chen M; Sun JJ
J Transl Med; 2020 Jul; 18(1):266. PubMed ID: 32611358
[TBL] [Abstract][Full Text] [Related]
31. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
[TBL] [Abstract][Full Text] [Related]
32. Early onset pancreatic malignancies: Clinical characteristics and survival associations.
Beeghly-Fadiel A; Luu HN; Du L; Shi C; McGavic DP; Parikh AA; Raskin L
Int J Cancer; 2016 Nov; 139(10):2169-77. PubMed ID: 27416564
[TBL] [Abstract][Full Text] [Related]
33. Lifetime alcohol intake and pancreatic cancer incidence and survival: findings from the Melbourne Collaborative Cohort Study.
Jayasekara H; English DR; Hodge AM; Room R; Hopper JL; Milne RL; Giles GG; MacInnis RJ
Cancer Causes Control; 2019 Apr; 30(4):323-331. PubMed ID: 30798509
[TBL] [Abstract][Full Text] [Related]
34. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
[TBL] [Abstract][Full Text] [Related]
35. EFFECT OF SELECTED PROGNOSTIC AND RISK FACTORS ON SURVIVAL OF WOMEN WITH BREAST CANCER IN GEORGIA.
Vashakidze N; Mebonia N; Kereselidze M; Gvamichava R; Zhizhilashvili S
Georgian Med News; 2018 Jun; (279):23-28. PubMed ID: 30035717
[TBL] [Abstract][Full Text] [Related]
36. Clinical Characteristics and Prognosis of Osteoclast-like Giant Cell Tumors of the Pancreas Compared with Pancreatic Adenocarcinomas: A Population-Based Study.
Xu M; Chen W; Wang D; Nie M
Med Sci Monit; 2020 Jul; 26():e922585. PubMed ID: 32716010
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
[TBL] [Abstract][Full Text] [Related]
38. Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006.
Li XP; Cao GW; Sun Q; Yang C; Yan B; Zhang MY; Fu YF; Yang LM
Chin J Cancer; 2013 Sep; 32(9):512-9. PubMed ID: 23149312
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
